首页> 外文期刊>Peptides: An International Journal >Place aversion induced by microinjections of C-fragment of substance P into the dorsal periaqueductal gray of rats is mediated by tachykinin NK(1) receptors.
【24h】

Place aversion induced by microinjections of C-fragment of substance P into the dorsal periaqueductal gray of rats is mediated by tachykinin NK(1) receptors.

机译:通过速激肽NK(1)受体介导将P物质C片段的C片段微注射到大鼠导水管周围灰色中引起的位置厌恶。

获取原文
获取原文并翻译 | 示例
       

摘要

Neural circuits in the dorsal periaqueductal gray matter (dPAG) play an important role in the integration of defensive behavior. The neurokinin substance P causes conditioned place aversion when administered into this region. The present study examined whether these effects may be mimicked by its carboxy-terminal amino acid sequence and whether they are influenced by prior treatment with the tachykinin NK(1) receptor antagonist WIN51,708. The behavioral testing apparatus is a circular open field consisting of 4 uniform quadrants that are equally preferred by the rats prior to drug treatments. For conditioning, rats received drug injections on three consecutive days and were placed into their assigned quadrant. The carboxy-terminal analog (17.5 pmol/0.2 &mgr;l) applied into the dPAG produced place aversion effects with reduced time spent in the drug-paired quadrant on the testing day. The effects of the carboxy-terminal analog was antagonized by pretreatment with WIN51,708 (20 mg/kg, i.p.). Microinjection of WIN51,708 (20 mg/kg, i.p.), by its own, did not produce significant effects. These findings suggest that previous reports showing conditioned place aversion effects of SP injected into the dPAG are encoded by its carboxy-terminal sequence and due to its action on tachykinin NK(1) receptors.
机译:导水管周围灰质(dPAG)中的神经回路在防御行为的整合中起重要作用。当将神经激肽P给药到该区域时,会引起条件性位置反感。本研究检查了这些作用是否可以被其羧基末端氨基酸序列所模仿,以及它们是否受到速激肽NK(1)受体拮抗剂WIN51,708的先前治疗的影响。行为测试设备是一个圆形的开放区域,由4个均匀的象限组成,在药物治疗之前,老鼠同样偏爱它。为了进行调节,大鼠连续三天接受药物注射,并置于指定的象限中。应用于dPAG的羧基末端类似物(17.5 pmol / 0.2μl)产生了地方厌恶效应,并减少了测试当天在药物配对象限中所花费的时间。通过用WIN51,708(20mg / kg,腹膜内)预处理可拮抗羧基末端类似物的作用。单独注射WIN51,708(20 mg / kg,i.p.)不会产生明显的影响。这些发现表明,以前的报道显示了注入dPAG的SP的条件性位置厌恶效应是由其羧基末端序列编码的,并且归因于它对速激肽NK(1)受体的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号